AKIP Antibody (C-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP6512b
Background:
AKIP may act as a negative regulator of Aurora-A kinase, by down-regulation through proteasome-dependent degradation.
Other Names:
Aurora kinase A-interacting protein, AURKA-interacting protein, 28S ribosomal protein S38, mitochondrial, MRP-S38, AURKAIP1, AIP, AKIP, MRPS38
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6512b was selected from the C-term region of human AKIP. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: AURKAIP1
Gene ID: 54998
Primary Accession: Q9NWT8
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
AKIP may act as a negative regulator of Aurora-A kinase, by down-regulation through proteasome-dependent degradation.
Other Names:
Aurora kinase A-interacting protein, AURKA-interacting protein, 28S ribosomal protein S38, mitochondrial, MRP-S38, AURKAIP1, AIP, AKIP, MRPS38
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6512b was selected from the C-term region of human AKIP. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: AURKAIP1
Gene ID: 54998
Primary Accession: Q9NWT8
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review